HomeSearchInfection and Drug Resistance

Infection and Drug Resistance

Dove Medical Press Ltd · New Zealand · Est. 1885

ISSN1178-6973eISSN1178-6973
SJR Q2WOS SCIEScopus / SJRDOAJOpen Access
Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q2. Source: Clarivate Journal Citation Reports.

📊 Standing in its field
Where this journal ranks among others in the same subject area.
Q2
SJR · Scopus
Top 50% in field
Clarivate’s JCR quartile is a separate ranking and may differ
SJR Scorei
0.791
H-Indexi
93
SNIPi
1.004
Total Worksi
4,796
Total Citationsi
82,250
2yr Mean Citednessi
2.19
Open Impact Factor alternative
Retractions
6
Source: Retraction Watch

Aims & Scope

An international, peer-reviewed, open access journal that focuses on the optimal treatment of infection (bacterial, fungal, viral and parasitic) and the development and institution of preventative strategies to minimize the development and spread of resistance.

General Information

Country / RegionNew Zealand
Primary LanguageEnglish
1st Year Published1885
FrequencyIrregular
StatusActive (last: 2026)
Total Publications4,796
Publisher OrgDove Medical Press
OA Since2007
Visit Journal Website

Submission Info

Peer ReviewSingle-blind
OA LicenseCC BY, CC BY-NC
OA Rate

Ethics & Quality

COPE Member✗ No
OASPA Member✗ No
Not on Predatory Lists✓ Yes
Plagiarism Detection✓ Yes

Think.Check.Submit Compliance

9/11 · 82%
Do you know the journal / publisher?
Dove Medical Press Ltd
Does the journal have a website?
✓ Linked
Is the ISSN verified?
1178-6973 / 1178-6973
Indexed in a trusted database?
WoS, Scopus, DOAJ, PubMed
Peer review process documented?
Single-blind
Follows ethical publishing standards (COPE)?
N/A
Not on predatory/blacklists?
✓ Clean
Long-term digital preservation?
N/A
Plagiarism detection in place?
Yes
Listed in DOAJ (verified OA)?
DOAJ verified
Primary language documented?
English

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published
Citations received
384
13k
2019
470
15k
2020
551
12k
2021
735
9.8k
2022
705
7.9k
2023
563
2.8k
2024
599
1.6k
2025
487
102
2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Infectious DiseasesQ2
PharmacologyQ2
Pharmacology (medical)Q2

Subject Classification

Web of Science Categories

Infectious DiseasesPharmacology & Pharmacy

Scopus Categories

PharmacologyPharmacology (medical)Infectious Diseases

Research Topics (OpenAlex)

Antibiotic Resistance in BacteriaTuberculosis Research and EpidemiologyBacterial Identification and Susceptibility TestingAntibiotic Use and ResistanceAntibiotics Pharmacokinetics and EfficacyNosocomial Infections in ICUAntimicrobial Resistance in StaphylococcusPneumonia and Respiratory InfectionsAntifungal resistance and susceptibilityMycobacterium research and diagnosis

Frequently asked questions about Infection and Drug Resistance

Is Infection and Drug Resistance a predatory journal?

PubScope has no integrity flags on record for Infection and Drug Resistance: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Infection and Drug Resistance?

Infection and Drug Resistance is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 2.19.

Is Infection and Drug Resistance indexed in Scopus and Web of Science?

Infection and Drug Resistance is indexed in Web of Science, Scopus, DOAJ.

What is the aims and scope of Infection and Drug Resistance?

An international, peer-reviewed, open access journal that focuses on the optimal treatment of infection (bacterial, fungal, viral and parasitic) and the development and institution of preventative strategies to minimize the development and spread of resistance.

Compare This JournalFind Similar← Back to Search
Understand these signals
How to tell if a journal is predatoryWhat Q1–Q4 quartiles meanWeb of Science vs Scopus vs DOAJWhat is an APC?

Data updated: 2026-05-22 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref